RB
Roy Buchanan JMP Securities Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
32
Avg Return
Past Year
Past Year
52%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
97%
Neutral
3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Financials
Healthcare
Financials
Asset Management
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Market Outperform
Maintained
| $173 |
70%
upside
| 8 | +28% |
0
%
| 3 Oct ‘25 16 days ago |
|
|
|
Market Outperform
Initiated
| $38 |
29%
upside
| 1 | +13% |
0
%
| 24 Sep ‘25 25 days ago |
|
|
|
Market Outperform
Reiterated
| $32 |
226%
upside
| 3 | -3.3% |
0
%
| 22 Aug ‘25 1 month ago |
|
|
|
Market Outperform
Maintained
| $25 |
127%
upside
| 5 | +11% |
0
%
| 12 Aug ‘25 2 months ago |
|
|
|
Market Outperform
Maintained
| $14 |
328%
upside
| 1 | -11% |
0
%
| 17 Jun ‘25 4 months ago |
|
|
|
Market Outperform
Reiterated
| $10 |
87%
upside
| 2 | +21% |
0
%
| 28 May ‘25 4 months ago |
|
|
|
Market Outperform
Maintained
| $2 |
68%
upside
| 5 | +4.9% |
0
%
| 5 May ‘25 5 months ago |
|
|
|
Market Outperform
Reiterated
| $18 |
666%
upside
| 2 | +7.1% |
0
%
| 14 Mar ‘25 7 months ago |
|
|
|
Market Perform
Reiterated
| – | – | 1 | – |
–
| 13 Feb ‘25 8 months ago |
|
|
|
Market Outperform
Reiterated
| $4 |
45%
upside
| 2 | +16% |
0
%
| 11 Feb ‘25 8 months ago |
|
|
|
Market Outperform
Maintained
| $14 |
879%
upside
| 1 | -62% |
0
%
| 30 Jan ‘25 8 months ago |
|
|
|
Market Outperform
Reiterated
| $33 |
64%
downside
| 1 | +1,288% |
0
%
| 10 Jan ‘25 9 months ago |
|
|
|
Market Outperform
Maintained
| $7 | – | 1 | -67% |
0
%
| 21 Nov ‘24 11 months ago |
|